The DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index.
Molecular imaging in drug development
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Zwischenmolekulare Energiewanderung und Fluoreszenz
Förster, T. (1948) · Annalen der Physik · doi:10.1002/andp.19484370105 · Cited by 8,285
The price of innovation: new estimates of drug development costs
DiMasi, J. A., Hansen, R. W., & Grabowski, H. G. (2003) · Journal of Health Economics · doi:10.1016/s0167-6296(02)00126-1 · Cited by 4,265
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
Massoud, T. F., & Gambhir, S. S. (2003) · Genes & Development · doi:10.1101/gad.1047403 · Cited by 2,216
Self-citationMolecular imaging of cancer with positron emission tomography
Gambhir, S. S. (2002) · Nature Reviews Cancer · doi:10.1038/nrc882 · Cited by 1,656
Self-citationFarde, L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820070032005 · Cited by 1,419
Peptide-Labeled Near-Infrared Quantum Dots for Imaging Tumor Vasculature in Living Subjects
Cai, W., Shin, D.-W., Chen, K., Gheysens, O., Cao, Q., Wang, S. X., Gambhir, S. S., & Chen, X. (2006) · Nano Letters · doi:10.1021/nl052405t · Cited by 948
Self-citation(2001) · PubMed · Cited by 943
Molecular imaging in drug discovery and development
Rudin, M., & Weissleder, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1007 · Cited by 815
Cost of innovation in the pharmaceutical industry
DiMasi, J. A., Hansen, R. W., Grabowski, H. G., & Lasagna, L. (1991) · Journal of Health Economics · doi:10.1016/0167-6296(91)90001-4 · Cited by 754
In vivo molecular target assessment of matrix metalloproteinase inhibition
Bremer, C., Tung, C.-H., & Weissleder, R. (2001) · Nature Medicine · doi:10.1038/89126 · Cited by 726
Hutchings, M., Loft, A., Hansen, M., Pedersen, L. M., Buhl, T., Jurlander, J., Buus, S., Keiding, S., D'Amore, F., Boesen, A.-M., et al. (2006) · Blood · doi:10.1182/blood-2005-06-2252 · Cited by 726
Morgan, B., Thomas, A. L., Drevs, J., Hennig, J., Buchert, M., Jivan, A., Horsfield, M. A., Mross, K., Ball, H. A., Lee, L., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.092 · Cited by 652
Haubner, R., Wester, H. J., Weber, W., Mang, C., Ziegler, S. I., Goodman, S. L., Senekowitsch–Schmidtke, R., Kessler, H., & Schwaiger, M. (2001) · PubMed · Cited by 563
Rasey, J. S., Koh, W.-J., Evans, M. L., Peterson, L. M., Lewellen, T. K., Graham, M. M., & Krohn, K. A. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00325-2 · Cited by 562
Radiolabeled amino acids: basic aspects and clinical applications in oncology.
Jager, P. L., Vaalburg, W., Pruim, J., de Vries, E. G. E., Langen, K., & Piers, D. (2001) · PubMed · Cited by 558
In vivo detection and imaging of phosphatidylserine expression during programmed cell death
Blankenberg, F. G., Katsikis, P. D., Tait, J. F., Davis, R. E., Naumovski, L., Ohtsuki, K., Kopiwoda, S., Abrams, M. J., Darkes, M., Robbins, R. C., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6349 · Cited by 536
Haubner, R., Weber, W. A., Beer, A. J., Vabuliene, E., Reim, D., Sarbia, M., Becker, K.-F., Goebel, M., Hein, R., Wester, H.-J., et al. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020070 · Cited by 489
Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway
Kung, A. L., Zabludoff, S. D., France, D. S., Freedman, S. J., Tanner, E. A., Vieira, A., Cornell-Kennon, S., Lee, J., Wang, B., Wang, J., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.009 · Cited by 480
Lesko, L., & Atkinson, A. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.347 · Cited by 465
Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole
Koh, W.-J., Rasey, J. S., Evans, M. L., Grierson, J. R., Lewellen, T. K., Graham, M. M., Krohn, K. A., & Griffin, T. W. (1992) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(92)91001-4 · Cited by 463
Imaging Tumor Angiogenesis With Contrast Ultrasound and Microbubbles Targeted to α v β 3
Ellegala, D. B., Leong-Poi, H., Carpenter, J. E., Klibanov, A. L., Kaul, S., Shaffrey, M. E., Sklenar, J., & Lindner, J. R. (2003) · Circulation · doi:10.1161/01.cir.0000080326.15367.0c · Cited by 454
Risks in new drug development: Approval success rates for investigational drugs
DiMasi, J. A. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.115446 · Cited by 450
Spaepen, K., Stroobants, S., Dupont, P., Vandenberghe, P., Thomas, J., de Groot, T., Balzarini, J., De Wolf-Peeters, C., Mortelmans, L., & Verhoef, G. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf256 · Cited by 410
Mikhaeel, N. G., Hutchings, M., Fields, P. A., O'Doherty, M. J., & Timothy, A. R. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi272 · Cited by 401
Knockouts model the 100 best-selling drugs—will they model the next 100?
Zambrowicz, B. P., & Sands, A. T. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd987 · Cited by 393
In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM
Dehdashti, F., Mintun, M. A., Lewis, J. S., Bradley, J., Govindan, R., Laforest, R., Welch, M. J., & Siegel, B. A. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1130-4 · Cited by 368
Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting.
Haubner, R., Wester, H., Reuning, U., Senekowitsch–Schmidtke, R., Diefenbach, B., Kessler, H., Stöcklin, G., & Schwaiger, M. (1999) · PubMed · Cited by 356
Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006.
Czernin, J. G., Allen-Auerbach, M., & Schelbert, H. R. (2007) · PubMed · Cited by 355
Ntziachristos, V., Schellenberger, E. A., Ripoll, J., Yessayan, D., Graves, E., Bogdanov, A., Josephson, L., & Weissleder, R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401137101 · Cited by 348
Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas
Jacobs, A., Voges, J., Reszka, R., Lercher, M., Gossmann, A., Kracht, L., Kaestle, C., Wagner, R., Wienhard, K., & Heiss, W. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05904-9 · Cited by 347
Biomarkers and surrogate markers: An FDA perspective
Katz, R. (2004) · NeuroRX · doi:10.1602/neurorx.1.2.189 · Cited by 347
In vivo Near-Infrared Fluorescence Imaging of Integrin αvβ3 in Brain Tumor Xenografts
Chen, X., Conti, P. S., & Moats, R. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1956 · Cited by 347
Paulmurugan, R., Umezawa, Y., & Gambhir, S. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242594299 · Cited by 334
Self-citationLindsay, M. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1202 · Cited by 332
Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
Janssen, M. L., Oyen, W. J. G., Dijkgraaf, I., Massuger, L. F. A. G., Frielink, C., Edwards, D. S., Rajopadhye, M., Boonstra, H., Corstens, F. H. M., & Boerman, O. C. (2002) · PubMed · Cited by 331
Past, present, and future of annexin A5: from protein discovery to clinical applications.
Boersma, H. H., Kietselaer, B., Stolk, L. M., Bennaghmouch, A., Hofstra, L., Narula, J., Heidendal, G. A. K., & Reutelingsperger, C. P. M. (2005) · PubMed · Cited by 330
Positron Emission Tomography Scanning: Current and Future Applications
Czernin, J., & Phelps, M. E. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104028 · Cited by 328
Dehdashti, F., Grigsby, P. W., Mintun, M. A., Lewis, J. S., Siegel, B. A., & Welch, M. J. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)04477-2 · Cited by 326
D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics
Farde, L., Wiesel, F. A., Nordstr�m, A. L., & Sedvall, G. (1989) · Psychopharmacology · doi:10.1007/bf00442555 · Cited by 325
Positron Emission Tomography As an Imaging Biomarker
Weber, W. A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.6068 · Cited by 312
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-824_4 · Cited by 302
Willmann, J. K., Paulmurugan, R., Chen, K., Gheysens, O., Rodriguez-Porcel, M., Lutz, A. M., Chen, I. Y., Chen, X., & Gambhir, S. S. (2008) · Radiology · doi:10.1148/radiol.2462070536 · Cited by 301
Self-citationVesselle, H. J., Grierson, J. R., Muzi, M., Pugsley, J. M., Schmidt, R. A., Rabinowitz, P., Peterson, L. M., Vallières, E., & Wood, D. E. (2002) · PubMed · Cited by 300
Apoptosome dysfunction in human cancer
Hajra, K. M., & Liu, J. R. (2004) · Apoptosis · doi:10.1023/b:appt.0000045786.98031.1d · Cited by 291
Stevenson, J. P., Rosen, M., Sun, W., Gallagher, M., Haller, D. G., Vaughn, D., Giantonio, B., Zimmer, R., Petros, W. P., Stratford, M., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.986 · Cited by 291
Dehdashti, F., Flanagan, F. L., Mortimer, J. E., Katzenellenbogen, J. A., Welch, M. J., & Siegel, B. A. (1999) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050359 · Cited by 290
Belhocine, T., Steinmetz, N. D., Hustinx, R., Bartsch, P., Jérusalem, G., Seidel, L., Rigo, P., & Green, A. M. (2002) · PubMed · Cited by 289
Koh, W.-J., Bergman, K. S., Rasey, J. S., Peterson, L. M., Evans, M. L., Graham, M. M., Grierson, J. R., Lindsley, K. L., Lewellen, T. K., Krohn, K. A., et al. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)00170-4 · Cited by 288
Hawkins, D. S., Schuetze, S. M., Butrynski, J. E., Rajendran, J. G., Vernon, C. B., Conrad, E. U., & Eary, J. F. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.7079 · Cited by 286
Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.
Zhang, X., Xiong, Z., Wu, Y., Cai, W., Tseng, J. R., Gambhir, S. S., & Chen, X. S. (2006) · PubMed · Cited by 282
Self-citationSchuster, D. M., Votaw, J. R., Nieh, P. T., Yu, W., Nye, J. A., Master, V. A., Bowman, F. D., Issa, M. M., & Goodman, M. M. (2007) · PubMed · Cited by 275
Acoustically Active Lipospheres Containing Paclitaxel: A New Therapeutic Ultrasound Contrast Agent
UNGER, E. C., McCREERY, T. P., SWEITZER, R. H., CALDWELL, V. E., & WU, Y. (1998) · Investigative Radiology · doi:10.1097/00004424-199812000-00007 · Cited by 267
Jung, J. C., & Schnitzer, M. J. (2003) · Optics Letters · doi:10.1364/ol.28.000902 · Cited by 266
Jayson, G. C., Zweit, J., Jackson, A., Mulatero, C., Julyan, P., Ranson, M., Broughton, L., Wagstaff, J., Hakannson, L., Groenewegen, G., et al. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.19.1484 · Cited by 258
Beer, A. J., Haubner, R., Goebel, M., Luderschmidt, S., Spilker, M. E., Wester, H., Weber, W., & Schwaiger, M. (2005) · PubMed · Cited by 258
Van den Abbeele, A. D., & Badawi, R. D. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)80604-9 · Cited by 257
Optical Imaging of Matrix Metalloproteinase–2 Activity in Tumors: Feasibility Study in a Mouse Model
Bremer, C., Bredow, S., Mahmood, U., Weissleder, R., & Tung, C.-H. (2001) · Radiology · doi:10.1148/radiol.2212010368 · Cited by 255
New drug development in the United States from 1963 to 1999
DiMasi, J. A. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.115132 · Cited by 251
Noninvasive real-time imaging of apoptosis
Laxman, B., Hall, D. E., Bhojani, M. S., Hamstra, D. A., Chenevert, T. L., Ross, B. D., & Rehemtulla, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252644499 · Cited by 247
Hoekstra, C. J., Stroobants, S. G., Smit, E. F., Vansteenkiste, J., van Tinteren, H., Postmus, P. E., Golding, R. P., Biesma, B., Schramel, F. J. H. M., van Zandwijk, N., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.1189 · Cited by 247
Monitoring Response to Anticancer Therapy by Targeting Microbubbles to Tumor Vasculature
Korpanty, G., Carbon, J. G., Grayburn, P. A., Fleming, J. B., & Brekken, R. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1313 · Cited by 245
PET: Molecular Imaging and Its Biological Applications
(2007) · Radiology · doi:10.1148/radiol.2422062606 · Cited by 238
Thomas, J. P., Arzoomanian, R. Z., Alberti, D., Marnocha, R., Lee, F., Friedl, A., Tutsch, K., Dresen, A., Geiger, P., Pluda, J., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.120 · Cited by 223
Katz‐Brull, R., Seger, D., Rivenzon‐Segal, D., Rushkin, E., & Degani, H. (2002) · PubMed · Cited by 221
The Progress and Promise of Molecular Imaging Probes in Oncologic Drug Development
Kelloff, G. J., Krohn, K. A., Larson, S. M., Weissleder, R., Mankoff, D. A., Hoffman, J. M., Link, J. M., Guyton, K. Z., Eckelman, W. C., Scher, H. I., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1302 · Cited by 220
Assessment of Pharmacodynamic Vascular Response in a Phase I Trial of Combretastatin A4 Phosphate
Anderson, H. L., Yap, J. T., Miller, M. P., Robbins, A., Jones, T., & Price, P. M. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.186 · Cited by 217
Buck, A. K., Schirrmeister, H., Hetzel, M., Heide, M. V. D., Halter, G., Glatting, G., Mattfeldt, T., Liewald, F., Reske, S. N., & Neumaier, B. (2002) · PubMed · Cited by 213
Dual-targeted Contrast Agent for US Assessment of Tumor Angiogenesis in Vivo
Willmann, J. K., Lutz, A. M., Paulmurugan, R., Patel, M. R., Chu, P., Rosenberg, J., & Gambhir, S. S. (2008) · Radiology · doi:10.1148/radiol.2483072231 · Cited by 207
Self-citationSu, H., Bodenstein, C., Dumont, R. A., Seimbille, Y., Dubinett, S., Phelps, M. E., Herschman, H., Czernin, J., & Weber, W. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0368 · Cited by 202
Mankoff, D. A., Dunnwald, L. K., Gralow, J. R., Ellis, G. K., Schubert, E. K., Tseng, J. R., Lawton, T. J., Linden, H. M., & Livingston, R. B. (2003) · PubMed · Cited by 200
Imaging of apoptosis (programmed cell death) with 99mTc annexin V.
Blankenberg, F. G., Katsikis, P. D., Tait, J. F., Davis, R. E., Naumovski, L., Ohtsuki, K., Kopiwoda, S. Y., Abrams, M. J., & Strausś, H. W. (1999) · PubMed · Cited by 198
Sugar and Amino Acid Transport by Cells in Culture — Differences between Normal and Malignant Cells
Deykin, D., Balko, C., & Isselbacher, K. J. (1972) · New England Journal of Medicine · doi:10.1056/nejm197204272861707 · Cited by 190
Cai, W., Wu, Y., Chen, K., Cao, Q., Tice, D. A., & Chen, X. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1480 · Cited by 187
How molecular imaging is speeding up antiangiogenic drug development
Cai, W., Rao, J., Gambhir, S. S., & Chen, X. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0395 · Cited by 175
Self-citationBeer, A. J., Niemeyer, M., Carlsen, J., Sarbia, M., Nährig, J., Watzlowik, P., Wester, H.-J., Harbeck, N., & Schwaiger, M. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.045526 · Cited by 174
Hodé, Y., Reimold, M., Demazières, A., Reischl, G., Bayle, F., Nuss, P., Hameg, A., Dib, M., & Macher, J. P. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2172-z · Cited by 173
Wang, Y., Hailey, J., Williams, D., Wang, Y., Lipari, P., Malkowski, M., Wang, X., Xie, L., Li, G., Saha, D., et al. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0048 · Cited by 171
Tomographic Fluorescence Mapping of Tumor Targets
Montet, X., Ntziachristos, V., Grimm, J., & Weissleder, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0382 · Cited by 168
Beer, A. J., Lorenzen, S., Metz, S., Herrmann, K., Watzlowik, P., Wester, H.-J., Peschel, C., Lordick, F., & Schwaiger, M. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.045864 · Cited by 167
Levine, E. A., Farmer, M. R., Clark, P., Mishra, G., Ho, C., Geisinger, K. R., Melin, S. A., Lovato, J., Oaks, T., & Blackstock, A. W. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000208430.07050.61 · Cited by 165
Franco, M., Man, S., Chen, L., Emmenegger, U., Shaked, Y., Cheung, A. M., Brown, A. S., Hicklin, D. J., Foster, F. S., & Kerbel, R. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3295 · Cited by 162
PET imaging of cellular proliferation
Mankoff, D. A., Shields, A. F., & Krohn, K. A. (2005) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2004.09.005 · Cited by 161
Abdollahi, A., Lipson, K. E., Sckell, A., Zieher, H., Klenke, F. M., Poerschke, D., Roth, A. K., Han, X., Krix, M., Bischof, M., et al. (2003) · PubMed · Cited by 160
Biomarkers in Imaging: Realizing Radiology’s Future
Smith, J. J., Sorensen, A. G., & Thrall, J. H. (2003) · Radiology · doi:10.1148/radiol.2273020518 · Cited by 159
PROTEIN-PROTEIN INTERACTIONS: a molecular cloning manual
Golemis, E. A. (2017) · Cited by 158
Leyton, J., Latigo, J. R., Perumal, M., Dhaliwal, H., He, Q., & Aboagye, E. O. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4008 · Cited by 153
Imaging hypoxia and angiogenesis in tumors
Rajendran, J. G., & Krohn, K. A. (2005) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2004.08.004 · Cited by 152
Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapy
van Hagen, P. M., Breeman, W. A. P., Bernard, H. F., Schaar, M., Mooij, C. M., Srinivasan, A., Schmidt, M. A., Krenning, E. P., & de Jong, M. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000820)90:4<186::aid-ijc2>3.0.co;2-p · Cited by 142
αvβ3-integrin imaging: a new approach to characterise angiogenesis?
Haubner, R. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0136-0 · Cited by 134
Veit, P., Antoch, G., Stergar, H., Bockisch, A., Forsting, M., & Kuehl, H. (2005) · European Radiology · doi:10.1007/s00330-005-2767-0 · Cited by 133
Overcoming resistance of cancer cells to apoptosis
Hersey, P., & Zhang, X. D. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10256 · Cited by 132
Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo
Shah, K., Tang, Y., Breakefield, X. O., & Weissleder, R. (2003) · Oncogene · doi:10.1038/sj.onc.1206748 · Cited by 131
Molecular Imaging of Antiangiogenic Agents
Rehman, S., & Jayson, G. C. (2005) · The Oncologist · doi:10.1634/theoncologist.10-2-92 · Cited by 131
Eschmann, S. M., Friedel, G., Paulsen, F., Reimold, M., Hehr, T., Budach, W., Langen, H.-J., & Bares, R. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0273-5 · Cited by 126
Monitoring gene therapy with reporter gene imaging
Ray, P., Bauer, E. M., Lyer, M., Barrio, J. R., Satyamurthy, N., Phelps, M. E., Herschman, H. R., & Gambhir, S. S. (2001) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2001.26209 · Cited by 121
Self-citationMolecular Imaging of Drug-Modulated Protein-Protein Interactions in Living Subjects
Paulmurugan, R., Massoud, T. F., Huang, J., & Gambhir, S. S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2972 · Cited by 115
Self-citationGinos, J. Z., Cooper, A. J. L., DHAWAN, V. M., Lai, J. C. K., Strother, S. C., Alcock, N. W., & Rottenberg, D. A. (1987) · PubMed · Cited by 115
Gee, M. S., Saunders, H., Lee, J. C., Sanzo, J. F., Jenkins, W. T., Evans, S. M., Trinchieri, G., Sehgal, C. M., Feldman, M. D., & Lee, W. M. F. (2001) · PubMed · Cited by 110
De, A., Loening, A. M., & Gambhir, S. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4623 · Cited by 110
Self-citationFunctional imaging of intratumoral hypoxia
Foo, S. S., Abbott, D. F., Lawrentschuk, N., & Scott, A. M. (2004) · Molecular Imaging and Biology · doi:10.1016/j.mibio.2004.06.007 · Cited by 109
Tumour dose response to the antivascular agent ZD6126 assessed by magnetic resonance imaging
Robinson, S. P., McIntyre, D. J. O., Checkley, D., Tessier, J. J. L., Howe, F. A., Griffiths, J. R., Ashton, S., Ryan, A. J., Blakey, D. C., & Waterton, J. C. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600926 · Cited by 109
Paulmurugan, R., & Gambhir, S. S. (2007) · Analytical Chemistry · doi:10.1021/ac062053q · Cited by 108
Self-citationCurrent State of Imaging Protein-Protein Interactions In Vivo with Genetically Encoded Reporters
Villalobos, V. M., Naik, S. U., & Piwnica-Worms, D. R. (2007) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.9.060906.152044 · Cited by 105
De, A., & Gambhir, S. S. (2005) · The FASEB Journal · doi:10.1096/fj.05-4628fje · Cited by 104
Self-citationUsing imaging biomarkers to accelerate drug development and clinical trials
Pien, H. H., Fischman, A. J., Thrall, J. H., & Sorensen, A. G. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03334-3 · Cited by 103
Pharmacokinetic Imaging: A Noninvasive Method for Determining Drug Distribution and Action
Fischman, A. J., Alpert, N. M., & Rubin, R. H. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241080-00003 · Cited by 101
An intramolecular folding sensor for imaging estrogen receptor–ligand interactions
Paulmurugan, R., & Gambhir, S. S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607385103 · Cited by 94
Self-citationThe advantage of using positron emission tomography in drug research
Farde, L. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)40002-9 · Cited by 94
Rehemtulla, A., Hall, D. E., Stegman, L. D., Prasad, U., Chen, G., Bhojani, M. S., Chenevert, T. L., & Ross, B. D. (2002) · Molecular Imaging · doi:10.1162/153535002753395707 · Cited by 94
Gene Therapy Progress and Prospects: Noninvasive imaging of gene therapy in living subjects
Min, J., & Gambhir, S. S. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302191 · Cited by 93
Self-citationMolecular imaging applications for immunology
Hildebrandt, I. J., & Gambhir, S. S. (2004) · Clinical Immunology · doi:10.1016/j.clim.2003.12.018 · Cited by 84
Self-citationBench, C. J., Lammertsma, A. A., Grasby, P. M., Dolan, R. J., Frackowiak, R. S. J., Warrington, S., Boyce, M. J., Gunn, K. P., & Brannick, L. Y. (1996) · Psychopharmacology · doi:10.1007/bf02245614 · Cited by 84
Acridine derivatives activate p53 and induce tumor cell death through bax
Wang, W., Ho, W. C., Dicker, D. T., MacKinnon, C., Winkler, J. D., Marmorstein, R., & El‐Deiry, W. S. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.8.2134 · Cited by 83
Saleem, A., Harte, R., Matthews, J. C., Osman, S., Brady, F., Luthra, S. K., Brown, G. D., Bleehen, N. M., Connors, T., Jones, T., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1421 · Cited by 80
Reporter gene imaging of protein–protein interactions in living subjects
Massoud, T. F., Paulmurugan, R., De, A., Ray, P., & Gambhir, S. S. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2007.01.007 · Cited by 79
Self-citationIn vivo tumor angiogenesis imaging with site-specific labeled 99mTc-HYNIC-VEGF
Blankenberg, F. G., Backer, M. V., Levashova, Z. B., et al. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0099-1 · Cited by 77
Corsten, M. F., Hofstra, L., Narula, J., & Reutelingsperger, C. P. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3000 · Cited by 76
Glaser, M., Collingridge, D. R., Aboagye, E. O., Bouchier‐Hayes, L., Hutchinson, O. C., Martin, S. J., Price, P., Brady, F., & Luthra, S. K. (2002) · Applied Radiation and Isotopes · doi:10.1016/s0969-8043(02)00239-7 · Cited by 75
Kissel, J., Brix, G., Bellemann, M. E., Strauss, L. G., Dimitrakopoulou‐Strauss, A., Port, R., Haberkorn, U., & Lorenz, W. (1997) · PubMed · Cited by 72
Gene therapy imaging in patients for oncological applications
Peñuelas, I., Haberkorn, U., Yaghoubi, S. S., & Gambhir, S. S. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1928-3 · Cited by 68
Self-citationMolecular Imaging in Drug Discovery and Development: Potential and Limitations of Nonnuclear Methods
Rudin, M., Rausch, M., & Stoeckli, M. (2005) · Molecular Imaging and Biology · doi:10.1007/s11307-004-0954-z · Cited by 67
Krix, M., Kiessling, F. M., Vosseler, S., Farhan, N., Mueller, M. M., Böhlen, P., Fusenig, N. E., & Delorme, S. (2003) · PubMed · Cited by 66
Molecular imaging of homodimeric protein–protein interactions in living subjects
Massoud, T. F., Paulmurugan, R., & Gambhir, S. S. (2004) · The FASEB Journal · doi:10.1096/fj.03-1128fje · Cited by 63
Self-citationImaging DNA synthesis in vivo with 18F-FMAU and PET.
Sun, H., Mangner, T. J., Collins, J. M., Muzik, O., Douglas, K. A., & Shields, A. F. (2005) · Journal of Nuclear Medicine · Cited by 62
Inoue, T., Kim, E. E., Wallace, S., Yang, D. J., Wong, F. C., Bassa, P., Cherif, A., Delpassand, E. S., Buzdar, A. U., & Podoloff, D. A. (1996) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.1996.11.235 · Cited by 59
Luker, K. E., & Piwnica-Worms, D. R. (2004) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(04)85019-5 · Cited by 57
Medical imaging in pharmaceutical clinical trials: what radiologists should know
Wáng, Y. X. J. (2005) · Clinical Radiology · doi:10.1016/j.crad.2005.04.016 · Cited by 54
Solomon, B., Binns, D., Roselt, P. D., Weibe, L. I., McArthur, G. A., Cullinane, C. M., & Hicks, R. J. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0066 · Cited by 50
Visualizing protein–protein interactions in living animals
Luker, G. D., Sharma, V., & Piwnica-Worms, D. R. (2003) · Methods · doi:10.1016/s1046-2023(02)00285-2 · Cited by 49
Bertolotto, M., Pozzato, G., Crocè, L. S., Nascimben, F., Gasparini, C., Cova, M. A., & Tiribelli, C. (2005) · Investigative Radiology · doi:10.1097/01.rli.0000188363.93670.45 · Cited by 47
Improved early clinical development through human microdosing studies
Wilding, I. R., & Bell, J. A. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03509-9 · Cited by 40
Less is more: the human microdosing concept
Garner, R. C. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03418-5 · Cited by 40
Wu, K., Cho, Y. S., Katz, J. P., Ponomarev, V., Chen‐Kiang, S., Danishefsky, S. J., & Moore, M. A. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504512102 · Cited by 37
Magnetic resonance and fluorescence based molecular imaging technologies
Sosnovik, D. E., & Weissleder, R. (2005) · Birkhäuser Basel eBooks · doi:10.1007/3-7643-7426-8_3 · Cited by 36
Positron Emission Tomography Imaging of Cell Proliferation in Oncology
Kenny, L. M., Aboagye, E. O., & Price, P. (2003) · Clinical Oncology · doi:10.1016/j.clon.2003.10.009 · Cited by 32
Clinical molecular imaging with positron emission tomography
Saleem, A., Charnley, N., & Price, P. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.02.021 · Cited by 31
Imaging biomarkers as surrogate endpoints for drug development
Richter, W. S. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0129-z · Cited by 28
Kim, Y. R., Yudina, A., Figueiredo, J.-L., Reichardt, W., Hu‐Lowe, D. D., Petrovsky, A., Kang, H. W., Torres, D. M., Mahmood, U., Weissleder, R., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-03-2619 · Cited by 28
EORTC Cutaneous Lymphoma Task Force
Knobler, R., Burg, G., Whittaker, S. J., & Baila, L. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00466-x · Cited by 25
Hsu, C., Chen, C., Chen, L., Wu, C.-Y., Hsieh, F., & Cheng, A. (2005) · Radiology · doi:10.1148/radiol.2352040271 · Cited by 25
Quantitative Assay Development for PET
Gambhir, S. S. (2004) · Springer eBooks · doi:10.1007/978-0-387-22529-6_2 · Cited by 25
Self-citationBombardieri, E. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0147-x · Cited by 16
Imaging protein–protein interactions in living subjects
Paulmurugan, R., Ray, P., De, A., Chan, C. T., & Gambhir, S. S. (2005) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2005.02.005 · Cited by 12
Self-citationImaging Gene Expression: Concepts and Future Outlook
Schipper, M. L., & Gambhir, S. S. (2006) · Medical radiology · doi:10.1007/3-540-30005-8_18 · Cited by 11
Self-citationThe Future of Imaging in Drug Discovery
Schmidt, M. E. (1999) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1999.tb05938.x · Cited by 5
Cited by
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Chemistry and Biology Of Multicomponent Reactions
Dömling, A., Wang, W., & Wang, K. (2012) · Chemical Reviews · doi:10.1021/cr100233r · Cited by 2,547
Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery
Torchilin, V. P. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4333 · Cited by 1,663
Biosensors and their applications – A review
Mehrotra, P. (2016) · Journal of Oral Biology and Craniofacial Research · doi:10.1016/j.jobcr.2015.12.002 · Cited by 1,526
Multifunctional nanoparticles for multimodal imaging and theragnosis
Lee, D.-E., Koo, H., Sun, I.-C., Ryu, J. H., Kim, K., & Kwon, I. C. (2012) · Chem. Soc. Rev. · doi:10.1039/c2cs15261d · Cited by 1,410
Metadata
- Authors
- Willmann, J. K., van Bruggen, N., Dinkelborg, L. M., & Gambhir, S. S.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2008-07
- Volume
- 7
- Issue
- 7
- Pages
- 591-607
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2042907121
- Cited by
- 1,171
- References
- 146
- FWCI
- 6.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.